Immuron (IMRN) Revenue (2016 - 2024)

Immuron's (IMRN) quarterly Revenue came in at -$7958490935.5 billion in Q4 2024, down 337856958181987.6% year-on-year from N/an in Q1 2024, and down 337856958181987.6% quarter-over-quarter from $2.4 million in Q4 2023.

Immuron (IMRN) Revenue (2016 - 2024) Analysis & Trends

Immuron's Revenue history runs 9 years deep, the most recent figure standing at -$7958490935.5 billion for Q4 2024.

  • On a quarterly basis, Revenue fell 337856958181987.6% year-over-year to -$7958490935.5 billion in Q4 2024; TTM through Dec 2024 was -$7958490935.5 billion, a 263189891376702.1% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, up 46.88% from the prior year.
  • Revenue slipped to -$7958490935.5 billion in Q4 2024 per IMRN's latest filing, from $2.4 million in the prior quarter.
  • Across five years, Revenue topped out at $2.4 million in Q4 2023 and bottomed at -$7958490935.5 billion in Q4 2024.
  • The 5-year median for Revenue is $42316.4 (2021), against an average of -$1326415155.9 billion.
  • Across the five-year window, Revenue jumped 11389249.91% in 2021 and sank 337856958181987.6% in 2024, its largest moves.
  • Year by year, Revenue stood at $0.01 in 2020, then soared by 11389249.91% to $1690.7 in 2021, then soared by 34421.0% to $583646.0 in 2022, then soared by 303.6% to $2.4 million in 2023, then sank by 337856958181987.6% to -$7958490935.5 billion in 2024.
  • Per Business Quant, the three latest IMRN Revenue figures stand at -$7958490935.5 billion (Q4 2024), $2.4 million (Q4 2023), and $82942.2 (Q2 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 1.30 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immuron 255.19 Mn 243.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -7,958,490,935.54 Bn
Dec 31, 2023 2.36 Mn
Jun 30, 2023 82,942.19
Dec 31, 2022 583,646.00
Dec 31, 2021 1,690.70
Dec 31, 2020 0.01
Dec 31, 2019 2.39 Mn
Dec 31, 2018 978,233.00
Dec 31, 2017 716,323.37
Dec 31, 2016 530,121.20
Jun 30, 2016 862,831.81